Eva Froňková - Concepedia

Author

Eva Froňková

Also Known As

Cinek Ondrej, E Fronkova, E Froňková, E. Fronkova, E. Froňková, Eva Fronkova, Eva Froňková, Eva Froňkova, Eva Froňková, F. Eva

150

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Charles University University Hospital in Motol University Hospital Schleswig-Holstein University of Lübeck Masaryk University

About

Eva Froňková is an author at Charles University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.3K
2	Cell Biology	5	5	171
3	Engineering	1	1	47
4	Public Health	1	1	37
5	Allergy	1	1	423

Eva Froňková

Publications

Citations

H-Index

Page 1

	Year	Citations
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich, Journal of Allergy and Clinical Immunology Clinical ImmunologyAllergyLymphocyte DevelopmentMedicineImmunodeficiencies	2018	423
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia Prisca Theunissen, Ester Mejstříková, Łukasz Sędek, Blood	2016	401
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology Lenka Hovorková, Markéta Žaliová, Nicola C. Venn, Blood	2017	128
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study Judith M. Boer, Arian van der Veer, Dimitris Rizopoulos, Leukemia International Collaborative StudyHematological MalignancyMedicinePrognostic ValueImmunology	2015	102
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group Nikola Hagedorn, Cécile Acquaviva, Eva Froňková, Blood	2007	99
CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia Andrea Inthal, Petra Zeitlhofer, Marion Zeginigg, Leukemia Hematological MalignancyPediatric HematologyMixed-phenotype Acute LeukemiaGeneticsHematology	2012	93
Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia Lucie Šrámková, Kateřina Mužíková, Eva Froňková, Pediatric Blood & Cancer	2006	89
Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL Michaela Kotrová, Vincent H. J. van der Velden, Jacques J. M. van Dongen, Bone Marrow Transplantation Genetic EpidemiologyPediatricsDiagnosisFalse-positive Mrd ResultsBetter Predicts Prognosis	2017	86
Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation Markéta Bloomfield, Veronika Kanderová, Zuzana Paračková, Journal of Clinical Immunology Translational MedicinePathogenesisImmunologyChronic Mucocutaneous CandidiasisClinical Mycology	2018	79
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing? Eva Froňková, Ester Mejstříková, Smadar Avigad, Leukemia Population ChildrenMedicineDifferential DiagnosisDiagnostic CriterionPediatrics	2008	73

Page 1